Philippines In New Move To Lower Retail Costs Of Key Drugs
This article was originally published in PharmAsia News
Executive SummaryThe Philippines once again has asked drug makers to submit a list of proposed reductions in the retail cost of their products as the government seeks to lower costs
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.